This article is a round-up of the latest point-of-care news on SelectScience. Included in this article is information on the very latest advances in cancer diagnostics, glucose monitoring in diabetes, and a fascinating video on pioneering wearable technology for real-time biomarker analysis.
Quest Diagnostics and Inovalon announced that they would be showcasing Data Diagnostics™, real-time analytics at the point of care, at the Healthcare Information and Management Systems Society Converence (HIMSS16), furthering the national roll-out of the solution.
VOC breath analysis is an area of increasing interest in cancer diagnosis. It has been found that different VOC breath patterns can be correlated to various different diseases. This exclusive editorial article looks at the latest advances in VOC breath analysis.
Abbott has announced that it has received approval from the Therapeutic Goods Administration (TGA) in Australia for its FreeStyle® Libre Flash Glucose Monitoring System, a revolutionary new glucose sensing technology for insulin-using Australians with diabetes.
During Self Care Week, Bradford Beating Diabetes and Siemens Healthcare Diagnostics formed a partnership to provide diabetes testing in the community for the residents of Bradford. The initiative helped identify those at risk of developing type 2 diabetes to ensure the most appropriate advice, care and support to prevent or delay the onset of the condition.
Sphere Medical announced that at the Symposium Intensivmedizin + Intensivpflege 2016, it would be discussing the potential application of its newly introduced Proxima patient-dedicated blood gas analyzer with isolation beds during outbreaks of infections, such as winter influenza, MRSA and VRE.
This informative guide explains the symptoms of anemia, how it is treated and how it is diagnosed. The guide includes some of the latest point-of-care analyzers available on the market and discusses factors that can influence haemoglobin measurement.
Dr Joshua Windmiller, Chief Technology Officer at Biolinq, reveals how their transdermal biosensor patches can continuously and non-invasively quantify blood biochemistry, with real-time streaming of the results to a smart device. He discusses how this pioneering technology could be developed for chronic healthcare monitoring.